Rhenman & Partners Asset Management Ab Penumbra Inc Transaction History

Rhenman & Partners Asset Management Ab

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$172.27 - $223.95 $3.96 Million - $5.15 Million	-23,000 Reduced 50.0%	23,000 $4.14 Million
Q1 2024 May 14, 2024	BUY	$220.09 - $273.15 $9.57 Million - $11.9 Million	43,500 Added 1740.0%	46,000 $10.3 Million
Q4 2023 Feb 13, 2024	BUY	$181.44 - $260.22 $453,600 - $650,550	2,500 New	2,500 $628,000

370

29.1M

220K

158K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $8.85B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Rhenman & Partners Asset Management Ab, based on Form 13F filings with the SEC.

Stay updated on Rhenman & Partners Asset Management Ab with notifications on news.